Abstract

Abstract Background Endometrial cancer (EC) is a common female genital tract malignancy of women, and colorectal cancer (CRC) is one of its risk factors. However, the mutual genes and molecular pathways shared by these two diseases have not yet been ascertained. Objectives In the present study, we aimed to reveal candidate biomarkers and molecular interactions between CRC and EC to understand the common disease mechanism. Materials and methods We performed differential analysis of CRC and EC microarray data by employing limma to reveal differentially expressed genes (DEGs). Then, we used mutual DEGs between these diseases to obtain significant biological processes and pathways by performing enrichment analyses. In addition, to reveal candidate biomarkers and regulatory transcripts, we analyzed different networks using bioinformatics tools. Results We identified 286 overlapped DEGs between CRC and EC transcriptomes datasets. Enrichment analysis of these aberrantly expressed genes revealed that they were significantly enriched in cancer pathways signaling. Based on topological analysis of the PPI network, we revealed 11 hub proteins including JUN, MYC, FOS, EGR1, LEF1, CDC42, CTGF, ADAM10, CYR61, FOXA1, and UBE2I. We also identified seven significant transcription factors (TFs) namely FOXC1, GATA2, YY1, E2F1, CREB1, HINFP, and FOXL1 and five miRNAs including hsa-miR-124-3p, hsa-miR-106b-5p, hsa-miR-501-3p, hsa-miR-29b-3p, and hsa-miR-145-5p that regulate expressions of the DEGs. Conclusion We have identified novel biomarkers and molecular pathways shared by CRC and EC that will help to understand underlying common molecular mechanisms and to develop potential therapeutics.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.